Online Education Program for Gynecologic Cancer Care
(BrachDEP Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Brachytherapy, Internal Radiation Therapy, Radioactive Seed Implantation, Online education for gynecologic cancer care?
Research shows that brachytherapy, a type of internal radiation therapy, is crucial in treating gynecologic cancers and has improved outcomes with less side effects due to advances in technology. Additionally, simulation-based education has been shown to boost confidence and competence in medical professionals, which can enhance the delivery of brachytherapy.12345
Is the Online Education Program for Gynecologic Cancer Care safe for humans?
Research on treatments like Brachytherapy and Radioactive Seed Implantation, which are related to the program, shows that safety procedures and guidelines are in place to ensure they are safe for humans. These treatments have been used safely in various conditions, including gynecological tumors, with established protocols to manage and monitor their use.678910
How is brachytherapy different from other treatments for gynecologic cancer?
Brachytherapy is unique because it involves placing radioactive material directly inside or near the tumor, allowing for a high dose of radiation to target the cancer while minimizing exposure to surrounding healthy tissue. This internal approach can lead to better outcomes and less toxicity compared to external radiation treatments.1581112
What is the purpose of this trial?
Although brachytherapy is an effective treatment modality for gynecological cancer, a significant proportion of patients develop late treatment-related vaginal toxicity, negatively impacting their quality of life and limiting recurrent disease detection by preventing adequate clinical examination during the post-treatment surveillance period. Consistent with the literature, results from a study at Princess Margaret revealed that current vaginal toxicity management education and training may be inadequate. The investigators seek to implement and evaluate a new online brachytherapy discharge education program (BrachDEP) to support patient engagement in self-management.
Research Team
Janet Papadakos, PhD, MEd
Principal Investigator
Princess Margaret Cancer Centre
Eligibility Criteria
This trial is for adults over 18 who can read and write in English, diagnosed with gynecologic cancer, and scheduled to receive brachytherapy at Princess Margaret Cancer Centre. They must be able to give informed consent. Those not undergoing brachytherapy are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive brachytherapy and are provided with either the online education program or standard care education
Education Intervention
Participants in the experimental arm receive access to online education modules in addition to standard care education
Follow-up
Participants are monitored for patient satisfaction, quality of life, and vaginal stenosis post-treatment
Treatment Details
Interventions
- Brachytherapy
- Online education
Brachytherapy is already approved in United States, European Union, Canada for the following indications:
- Prostate cancer
- Cervical cancer
- Breast cancer
- Skin cancer
- Esophageal cancer
- Prostate cancer
- Cervical cancer
- Breast cancer
- Skin cancer
- Esophageal cancer
- Brain tumors
- Prostate cancer
- Cervical cancer
- Breast cancer
- Skin cancer
- Esophageal cancer
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor